Drug Detail

Information about Lenvima

Generic Name	Lenvatinib
IND	E7080
Brand Name (US)	Lenvima
Manufacturer	Eisai Co.
Drug Type	Kinase inhibitor
Delivery	Oral
Approval Status	Approved for a non-GIST application
Indications	Thyroid Cancer, Advanced RCC, HCC
Overall Strategy	KIT and PDGFRA protein based
Strategy	Block KIT + Block related tumor signal paths
Drug Category	KIT/PDGFra/RET/FGFR/VEGFR inhibitor

Links
Trials of this drug
	Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure (LENVAGIST)

Trial results